Patients ( N = @ ) with type @ diabetes and hypertension ( mean seated systolic blood pressure -LSB- SBP -RSB- @-@ mmHg and diastolic blood pressure -LSB- DBP -RSB- @-@ mmHg ) were randomized ( double blind ) to @ mg or @ mg empagliflozin or placebo once daily for @ weeks .